Cerebrovascular manifestations of familial Mediterranean fever
https://doi.org/10.30629/2658-7947-2022-27-2-70-75
Abstract
This article provides an overview of modern concepts of cerebrovascular manifestations of familial Mediterranean fever (FMV), also known as periodic disease, and describes own clinical observation. Despite the relative infrequency of cerebrovascular accidents in the structure of the clinical phenomenology of FMV, common pathogenetic aspects of these diseases indicate the need for a detailed examination of patients with suspected FMV. In addition, insufficient awareness of physicians about autoinflammatory diseases (of which FMV is a prominent member) underlines the need to include FMV in the spectrum of differential diagnosis of ischemic stroke, including taking into account national characteristics.
About the Authors
A. A. Raskurazhev
Research Center of Neurology
Russian Federation
Russian Federation
Anton A. Raskurazhev – MD, PhD, senior researcher, 1st neurological department Research Center of Neurology, neurologist
Moscow, Volokolamskoe shosse, h. 80.
P. I. Kuznetsova
Research Center of Neurology
Russian Federation
Russian Federation
Moscow
M. M. Tanashyan
Research Center of Neurology
Russian Federation
Russian Federation
Moscow
References
1. Shohat M., Halpern G.J. Familial Mediterranean fever — a review. Genet. Med . 2011;13(6):487–98. https://doi.org/10.1097/GIM.0b013e3182060456
2. Siegal S. Benign paroxysmal peritonitis. Ann. Intern. Med . 1945;23(1):1.
3. Alghamdi M. Familial Mediterranean fever, review of the literature. Clin. Rheumatol . 2017;36(8):1707–1713. https://doi.org/1007/s10067-017-3715-5
4. Ozdogan H., Ugurlu S. Familial Mediterranean Fever. Presse Med. 2019. https://doi.org/10.1016/j.lpm.2018.08.014
5. Goldfinger S.E. Colchicine for familial Mediterranean fever. N. Engl. J. Med. 1972;287(25):1302.
6. Tufan A., Lachmann H.J. Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review. Turk. J. Med. Sci. 2020;50(SI–2):1591–1610. https://doi.org/10.3906/sag-2008-11
7. French F.M.F. Consortium. A candidate gene for familial Mediterranean fever. Nat. Genet. 1997;17(1):25–31.
8. Kalyoncu U., Eker A., Oguz K.K., Kurne A., Kalan I., Topcuoglu A.M. et al. Familial Mediterranean fever and central nervous system involvement: a case series. Medicine (Baltimore). 2010;89(2):75–84. https://doi.org/10.1097/MD.0b013e3181d5dca7
9. Feld O., Yahalom G., Livneh A. Neurologic and other systemic manifestations in FMF: published and own experience. Best Pract. Res. Clin. Rheumatol . 2012;26:119–133. https://doi.org/10.1016/j.berh.2012.01.004
10. Ben-Zvi I., Livneh A. Chronic inflammation in FMF: markers, risk factors, outcomes and therapy. Nat. Rev. Rheumatol. 2011;7:105–112. https://doi.org/10.1038/nrrheum.2010.181
11. Çetin G., Utku U., Atilla N., Gişi K., Sayarlioğlu M. Changes in Cerebral Blood Flow in Patients with Familial Mediterranean Fever. Noro Psikiyatr. Ars. 2017;54(2):105–107. https://doi.org/10.5152/npa.2016.12396
12. Vampertzi O., Papadopoulou-Legbelou K., Triantafyllou A., Douma S., Papadopoulou-Alataki E. Familial Mediterranean fever and atherosclerosis in childhood and adolescence. Rheumatol. Int. 2020;40:1–8. https://doi.org/10.1007/s00296-019-04457-8
13. Kofoed S.C., Wittrup H.H., Sillesen H., Nordestgaard B.G. Fibrinogen predicts ischaemic stroke and advanced atherosclerosis but not echolucent, rupture-prone carotid plaques: the Copenhagen City Heart Study. Eur. Heart J. 2003;24(6):567–576. https://doi.org/10.1016/s0195-668x(02)00467-0
14. Akdogan A., Calguneri M., Yavuz B., Arslan E.B., Kalyoncu U., Sahiner L. et al. Are familial Mediterranean fever (FMF) patients at increased risk for athero- sclerosis? Impaired endothelial function and increased intima media thickness are found in FMF. J. Am. Coll. Cardiol. 2006;48(11):2351–2353. https://doi.org/10.1016/j.jacc.2006.09.013
15. Luger S., Harter P.N., Mittelbronn M., Wagner M., Foerch C. Brain stem infarction associated with familial Mediterranean fever and central nervous system vasculitis. Clin. Exp. Rheumatol. 2013;31(3Suppl77):93–5.
16. Aghdashi M., Seidmardani S.M., Vossoughian S., Seyed Mokhtari S.A. Very Rare Presentation of Cerebrovascular Accident in 20-Year-Old Man With Familial Mediterranean Fever-Case Report. Clin. Med. Insights. Case Rep. 2018;11:1–3. https://doi.org/10.1177/1179547617749208
17. Watad A., Tiosano S., Yahav D., Comaneshter D., Shoenfeld Y., Cohen A.D., Amital H. Behcet’s disease and familial Mediterranean fever: two sides of the same coin or just an association? A cross-sectional study. Eur. J. Intern. Med. 2017;39:75–78. https://doi.org/10.1016/j.ejim.2016.10.011
18. Ishikawa H., Shindo A., Ii Y., Sakano S., Asahi M., Matsuura K., Kishida D. et al. Vertebral artery dissection associated with familial Mediterranean fever and Behçet’s disease. Ann. Clin. Transl. Neurol. 2019;6(5):974–978. https://doi.org/10.1002/acn3.773
19. Katsanos A.H., Hart R.G. New Horizons in Pharmacologic Therapy for Secondary Stroke Prevention. JAMA Neurol. 2020;77(10):1308–1317. https://doi.org/10.1001/jamaneu-rol.2020.2494
20. Ozen S., Demirkaya E., Erer B., Livneh A., Ben-Chetrit E., Giancane G. et al. EULAR recommendations for the management of familial Mediterranean fever. Ann. Rheum. Dis . 2016;75(4):644–651. https://doi.org/10.1136/annrheum-dis-2015-208690
21. Coban E., Adanir H. Platelet activation in patients with Familial Mediterranean Fever. Platelets. 2008;19(6):405–408. https://doi.org/10.1080/09537100802187121
22. Katsanos A.H., Palaiodimou L., Price C., Themistocleous M., Lemmens R., Michopoulos I. et al. An Updated Meta-Analysis of RCTs of Colchicine for Stroke Prevention in Patients with Coronary Artery Disease. J. Clin. Med. 2021;10(14):3110. https://doi.org/10.3390/jcm10143110
Review
For citations:
Raskurazhev A.A., Kuznetsova P.I., Tanashyan M.M. Cerebrovascular manifestations of familial Mediterranean fever. Russian neurological journal. 2022;27(2):70-75. (In Russ.) https://doi.org/10.30629/2658-7947-2022-27-2-70-75
Views:
483
Email this article 